Remedium Lifecare Limited (BOM:539561)

Market Cap	733.82M
Revenue (ttm)	15.49B
Net Income (ttm)	-206.84M
Shares Out	403.20M
EPS (ttm)	-0.40
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	459,918
Average Volume	756,587
Open	1.820
Previous Close	1.790
Day's Range	1.820 - 1.820
52-Week Range	1.580 - 27.425
Beta	1.31
RSI	39.16
Earnings Date	May 27, 2025

About Remedium Lifecare

Remedium Lifecare Limited, a pharmaceutical company, engages in the trading and sale of active pharmaceutical ingredients (API) and intermediates in India and internationally. The company offers API intermediates and other products for the use in iso propyl alcohol, cyclohexane di iso propyl amine, ethyl acetate, hydrazine hydrate, iso propyl alcohol, methylene di chloride, potassium carbonate powder, sodium bi-carbonate, potassium hydroxide flakes, sodium chloride and carbonate, amino isophthalic acid, tellurium(iv) oxide, grignard reagent, io...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1988
• Employees: 7
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539561

Financial Performance

In 2023, Remedium Lifecare's revenue was 40.42 billion, an increase of 692.75% compared to the previous year's 5.10 billion. Earnings were 327.30 million, an increase of 503.20%.